flufenamic acid has been researched along with 1,7-phenanthroline in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Schlaeger, M; Seidel, G; Wendel, U | 1 |
| Hatzidimitriou, AG; Kefala, LA; Kessissoglou, DP; Papadopoulos, AN; Perdih, F; Psomas, G; Tsiliou, S; Turel, I | 1 |
| Alhazza, IM; Alwasel, S; Danko, M; Hudecova, L; Jomova, K; Kozovska, Z; Kucerova, L; Lauro, P; Moncol, J; Rajcaniova, S; Simunkova, M; Svorc, L; Valko, M | 1 |
| Kaluđerović, GN; Morgan, I; Samoľová, E; Saoud, M; Smolko, L; Smolková, R | 1 |
5 other study(ies) available for flufenamic acid and 1,7-phenanthroline
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Activation of a specific human plasma kininogenase with trypsin and plasmin.
Topics: Angiotensin-Converting Enzyme Inhibitors; Endopeptidases; Enzyme Activation; Fibrinolysin; Flufenamic Acid; Humans; Iodobenzoates; Kininogens; Kinins; Lysine Carboxypeptidase; Phenanthrolines; Streptokinase; Time Factors; Trypsin | 1973 |
Cobalt(II) complexes with non-steroidal anti-inflammatory drugs and α-diimines.
Topics: 2,2'-Dipyridyl; Aminopyridines; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Biphenyl Compounds; Cations, Divalent; Cobalt; Coordination Complexes; Crystallography, X-Ray; Diflunisal; DNA; Flufenamic Acid; Free Radical Scavengers; Intercalating Agents; Kinetics; Mefenamic Acid; Methanol; Models, Molecular; Niflumic Acid; Phenanthrolines; Picrates; Serum Albumin | 2016 |
Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumi
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Biomimetic Materials; Cell Line, Tumor; Coordination Complexes; Copper; DNA; DNA Damage; Escherichia coli; Fenamates; Flufenamic Acid; Humans; Intercalating Agents; Mefenamic Acid; ortho-Aminobenzoates; Oxidation-Reduction; Phenanthrolines; Reactive Oxygen Species; Serum Albumin, Human; Superoxide Dismutase | 2019 |
Two isostructural Co(II) flufenamato and niflumato complexes with bathocuproine: Analogues with a different cytotoxic activity.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cobalt; Coordination Complexes; Drug Screening Assays, Antitumor; Flufenamic Acid; G1 Phase Cell Cycle Checkpoints; Humans; Ligands; Molecular Structure; Phenanthrolines; Structure-Activity Relationship | 2020 |